Announcement on Progress in Litigation Involved by the Company
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Progress in Litigation Involved by the Company
Filed with SSE ·
6ix hasn’t read this filing yet.
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix
Earlier from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Terminating the Issuance of Shares and Convertible Corporate Bonds to Purchase Assets and Raising Supporting Funds and Related Party Transactions, and the Withdrawal of Application Documents
- Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Application for ABA001 Injection
- Announcement on Litigation Results of the Company
- Announcement on Stock Repurchase, Shareholding Increase and Loan Extension
- Announcement on Deferring the Reply to the "Inquiry Letter Regarding the Review of Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.’s Share Issuance and Convertible Bond Issuance for Asset Acquisition and Raising of Supporting Funds, and Related Party Transaction"
Later from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Cooperative Investment with Private Fund
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of BTP4327
- Announcement on Voluntary Disclosure of External Investment
- Announcement on the Self-Inspection Report on Insider Trading During the Self-Inspection Period by Persons Aware of Material Non-public Information Related to the Termination of Issuance of Shares and Convertible Corporate Bonds to Acquire Assets, Raising Supporting Funds, and Related Party Transactions
Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.
Follow Beijing Sun-Novo Pharmaceutical Research